DocDollars

Verona Pharma, Inc.

NC · United States · Reporting entity ID 100001452761

Total reported 2019–2025
$9.60M
#502 of 2,960 reporting companies — 0% of all reported industry payments
$1.75M in general payments across 32,389 records, plus $7.85M in research funding across 783 records.

How it breaks down

General payments $1,751,814
Research funding $7,852,153

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Verona Pharma, Inc. reported $9.60M to US doctors and teaching hospitals from 2019 to 2025, ranking #502 of 2,960 reporting companies. 82% of that was research funding and 18% general payments such as consulting, speaking, food and travel. 32,389 general payment records and 783 research records were filed.

Common questions about Verona Pharma, Inc.

How much has Verona Pharma, Inc. paid US doctors?

Verona Pharma, Inc. reported $9,603,967 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,751,814 in general payments, $7,852,153 in research funding.

How does Verona Pharma, Inc. rank among drug and device companies?

It ranks #502 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Verona Pharma, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.